As India awaits the launch of obesity drug, Mounjaro, the debate on weight loss drugs and body image continues ...

The federal health insurance program has selected 15 additional drugs covered by Medicare Part D for its next round of price ...

Semaglutide — the active ingredient in the brand-name meds Ozempic, Wegovy, and Rybelsus — treats type 2 diabetes and obesity ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

As detailed in our previous updates, the IRA’s Medicare Drug Price Negotiation Program (the Negotiation Program or Program), ...

Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.

Doctors at the University of Utah’s Moran Eye Center have reviewed cases of nine patients who developed vision problems while ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new ...

People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why - There’s no direct link ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.